Systemic Inflammation Leads to Changes in the Intracellular Localization of KLK6 in Oligodendrocytes in Spinal Cord White Matter

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2023 Apr 17

PMID 37067738

Authors

Eriko Furube

Masahiro Ohgidani

Shigetaka Yoshida

Affiliations

Soon will be listed here.

Abstract

Axonal injury and demyelination occur in demyelinating diseases, such as multiple sclerosis, and the detachment of myelin from axons precedes its degradation. Paranodes are the areas at which each layer of the myelin sheath adheres tightly to axons. The destruction of nodal and paranodal structures during inflammation is an important pathophysiology of various neurological disorders. However, the underlying pathological changes in these structures remain unclear. Kallikrein 6 (KLK6), a serine protease produced by oligodendrocytes, is involved in demyelinating diseases. In the present study, we intraperitoneally injected mice with LPS for several days and examined changes in the localization of KLK6. Transient changes in the intracellular localization of KLK6 to paranodes in the spinal cord were observed during LPS-induced systemic inflammation. However, these changes were not detected in the upper part of brain white matter. LPS-induced changes were suppressed by minocycline, suggesting the involvement of microglia. Moreover, nodal lengths were elongated in LPS-treated wild-type mice, but not in LPS-treated KLK6-KO mice. These results demonstrate the potential involvement of KLK6 in the process of demyelination.

References

Fehmi J, Scherer S, Willison H, Rinaldi S . Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry. 2017; 89(1):61-71. DOI: 10.1136/jnnp-2016-315480. View

Guzman-Martinez L, Maccioni R, Andrade V, Navarrete L, Pastor M, Ramos-Escobar N . Neuroinflammation as a Common Feature of Neurodegenerative Disorders. Front Pharmacol. 2019; 10:1008. PMC: 6751310. DOI: 10.3389/fphar.2019.01008. View

Heneka M, Kummer M, Latz E . Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014; 14(7):463-77. DOI: 10.1038/nri3705. View

Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S . Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009; 73(10):768-74. PMC: 2848584. DOI: 10.1212/WNL.0b013e3181b6bb95. View

Buljevac D, Flach H, Hop W, Hijdra D, Laman J, Savelkoul H . Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 2002; 125(Pt 5):952-60. DOI: 10.1093/brain/awf098. View

Iwasaki A, Medzhitov R . Regulation of adaptive immunity by the innate immune system. Science. 2010; 327(5963):291-5. PMC: 3645875. DOI: 10.1126/science.1183021. View

Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J . Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. 2019; 9(1):5790. PMC: 6453933. DOI: 10.1038/s41598-019-42286-8. View

Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett P, Jensen F . The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 2002; 22(7):2478-86. PMC: 6758325. DOI: 20026268. View

Newman T, Woolley S, Hughes P, Sibson N, Anthony D, Perry V . T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain. 2001; 124(Pt 11):2203-14. DOI: 10.1093/brain/124.11.2203. View

10.

Retamal M, Froger N, Palacios-Prado N, Ezan P, Saez P, Saez J . Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci. 2007; 27(50):13781-92. PMC: 6673621. DOI: 10.1523/JNEUROSCI.2042-07.2007. View

11.

Li Y, Su P, Chen Y, Nie J, Yuan T, Wong A . The Eph receptor A4 plays a role in demyelination and depression-related behavior. J Clin Invest. 2022; 132(8). PMC: 9012277. DOI: 10.1172/JCI152187. View

12.

Chou C, Lee J, Tsai C, Lien L, Yin J, Lin C . Increased risk of non-multiple sclerosis demyelinating syndromes in patients with preexisting septicaemia: a nationwide retrospective cohort study. Postgrad Med J. 2019; 95(1124):307-313. PMC: 6613738. DOI: 10.1136/postgradmedj-2019-136667. View

13.

Yamanaka H, He X, Matsumoto K, Shiosaka S, Yoshida S . Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Brain Res Mol Brain Res. 1999; 71(2):217-24. DOI: 10.1016/s0169-328x(99)00187-4. View

14.

Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T . Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta. 1997; 1350(1):11-4. DOI: 10.1016/s0167-4781(96)00187-x. View

15.

Blaber S, Scarisbrick I, Bernett M, Dhanarajan P, Seavy M, Jin Y . Enzymatic properties of rat myelencephalon-specific protease. Biochemistry. 2002; 41(4):1165-73. DOI: 10.1021/bi015781a. View

16.

Scarisbrick I, Blaber S, Lucchinetti C, Genain C, Blaber M, Rodriguez M . Activity of a newly identified serine protease in CNS demyelination. Brain. 2002; 125(Pt 6):1283-96. DOI: 10.1093/brain/awf142. View

17.

Scarisbrick I, Yoon H, Panos M, Larson N, Blaber S, Blaber M . Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis. Brain Pathol. 2012; 22(5):709-22. PMC: 3360139. DOI: 10.1111/j.1750-3639.2012.00577.x. View

18.

Blaber S, Ciric B, Christophi G, Bernett M, Blaber M, Rodriguez M . Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J. 2004; 18(7):920-2. DOI: 10.1096/fj.03-1212fje. View

19.

Yoon H, Radulovic M, Wu J, Blaber S, Blaber M, Fehlings M . Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity. J Neurochem. 2013; 127(2):283-98. PMC: 4097186. DOI: 10.1111/jnc.12293. View

20.

Furube E, Kawai S, Inagaki H, Takagi S, Miyata S . Brain Region-dependent Heterogeneity and Dose-dependent Difference in Transient Microglia Population Increase during Lipopolysaccharide-induced Inflammation. Sci Rep. 2018; 8(1):2203. PMC: 5797160. DOI: 10.1038/s41598-018-20643-3. View